WO2001032127A3 - Procede et compositions pour traiter des maladies respiratoires - Google Patents

Procede et compositions pour traiter des maladies respiratoires Download PDF

Info

Publication number
WO2001032127A3
WO2001032127A3 PCT/US2000/030113 US0030113W WO0132127A3 WO 2001032127 A3 WO2001032127 A3 WO 2001032127A3 US 0030113 W US0030113 W US 0030113W WO 0132127 A3 WO0132127 A3 WO 0132127A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
PCT/US2000/030113
Other languages
English (en)
Other versions
WO2001032127A2 (fr
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to PL00355261A priority Critical patent/PL355261A1/xx
Priority to IL14936700A priority patent/IL149367A0/xx
Application filed by Smithkline Beecham Corp, Peter N Goodfellow, Richard Nieman, Theodore J Torphy filed Critical Smithkline Beecham Corp
Priority to MXPA02004350A priority patent/MXPA02004350A/es
Priority to KR1020027005609A priority patent/KR20020057988A/ko
Priority to EP00975533A priority patent/EP1225866A4/fr
Priority to EA200200518A priority patent/EA200200518A1/ru
Priority to APAP/P/2002/002496A priority patent/AP2002002496A0/en
Priority to AU13575/01A priority patent/AU1357501A/en
Priority to DZ003225A priority patent/DZ3225A1/fr
Priority to CA002388333A priority patent/CA2388333A1/fr
Priority to JP2001534335A priority patent/JP2003513028A/ja
Priority to HU0203152A priority patent/HUP0203152A3/hu
Priority to BR0015270-6A priority patent/BR0015270A/pt
Priority to SK759-2002A priority patent/SK7592002A3/sk
Publication of WO2001032127A2 publication Critical patent/WO2001032127A2/fr
Publication of WO2001032127A3 publication Critical patent/WO2001032127A3/fr
Priority to NO20022057A priority patent/NO20022057L/no
Priority to BG106748A priority patent/BG106748A/xx
Priority to HK02109234.5A priority patent/HK1049107A1/zh
Priority to US11/217,532 priority patent/US20060035877A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne le traitement de maladies respiratoires telles que la maladie respiratoire obstructive chronique ou l'asthme par l'administration d'un inhibiteur de phosphodiestérase 4 en combinaison avec un corticostéroïde anti-inflammatoire.
PCT/US2000/030113 1999-11-02 2000-11-01 Procede et compositions pour traiter des maladies respiratoires WO2001032127A2 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
JP2001534335A JP2003513028A (ja) 1999-11-02 2000-11-01 肺疾患を治療するための方法および組成物
CA002388333A CA2388333A1 (fr) 1999-11-02 2000-11-01 Procede et compositions pour traiter des maladies respiratoires
HU0203152A HUP0203152A3 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases
IL14936700A IL149367A0 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases
EP00975533A EP1225866A4 (fr) 1999-11-02 2000-11-01 Procede et compositions pour traiter des maladies respiratoires
EA200200518A EA200200518A1 (ru) 1999-11-02 2000-11-01 Способ и композиция для лечения заболеваний легких
APAP/P/2002/002496A AP2002002496A0 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases.
AU13575/01A AU1357501A (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases
DZ003225A DZ3225A1 (fr) 1999-11-02 2000-11-01 Methode et compositions pour le traitement des maladies pulmonaires
PL00355261A PL355261A1 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases
KR1020027005609A KR20020057988A (ko) 1999-11-02 2000-11-01 폐 질환을 치료하는 방법 및 조성물
MXPA02004350A MXPA02004350A (es) 1999-11-02 2000-11-01 Metodo y composiciones para tratar enfermedades pulmonares.
BR0015270-6A BR0015270A (pt) 1999-11-02 2000-11-01 Método e composições para tratamento de doenças pulmonares
SK759-2002A SK7592002A3 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases
NO20022057A NO20022057L (no) 1999-11-02 2002-04-30 Fremgangsmåte og sammensetning for å behandle lungesykdommer
BG106748A BG106748A (en) 1999-11-02 2002-05-29 Method and compositions for treating pulmonary diseases
HK02109234.5A HK1049107A1 (zh) 1999-11-02 2002-12-19 用於治療肺疾病的方法和組合物
US11/217,532 US20060035877A1 (en) 1999-11-02 2005-09-01 Method and compositions for treating pulmonary diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
US60/163,158 1999-11-02

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10129311 A-371-Of-International 2002-05-02
US10/847,223 Continuation US20040214805A1 (en) 1999-11-02 2004-05-17 Method and compositions for treating pulmonary diseases

Publications (2)

Publication Number Publication Date
WO2001032127A2 WO2001032127A2 (fr) 2001-05-10
WO2001032127A3 true WO2001032127A3 (fr) 2001-12-06

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030113 WO2001032127A2 (fr) 1999-11-02 2000-11-01 Procede et compositions pour traiter des maladies respiratoires

Country Status (29)

Country Link
EP (1) EP1225866A4 (fr)
JP (1) JP2003513028A (fr)
KR (1) KR20020057988A (fr)
CN (1) CN1387404A (fr)
AP (1) AP2002002496A0 (fr)
AR (1) AR029189A1 (fr)
AU (1) AU1357501A (fr)
BG (1) BG106748A (fr)
BR (1) BR0015270A (fr)
CA (1) CA2388333A1 (fr)
CO (1) CO5261512A1 (fr)
CZ (1) CZ20021512A3 (fr)
DZ (1) DZ3225A1 (fr)
EA (1) EA200200518A1 (fr)
EC (1) ECSP003747A (fr)
HK (1) HK1049107A1 (fr)
HU (1) HUP0203152A3 (fr)
IL (1) IL149367A0 (fr)
MA (1) MA26841A1 (fr)
MX (1) MXPA02004350A (fr)
NO (1) NO20022057L (fr)
OA (1) OA12076A (fr)
PE (1) PE20011005A1 (fr)
PL (1) PL355261A1 (fr)
SK (1) SK7592002A3 (fr)
TR (1) TR200201211T2 (fr)
TW (1) TWI242431B (fr)
WO (1) WO2001032127A2 (fr)
ZA (1) ZA200203435B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL210463B1 (pl) * 2001-09-19 2012-01-31 Nycomed Gmbh Zastosowanie kombinacji roflumilastu z diklofenakiem w leczeniu zapalnych chorób stawów
EP1463509A1 (fr) * 2001-10-31 2004-10-06 MERCK PATENT GmbH Inhibiteurs de la phosphodiesterase de type 4 et leurs utilisations
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
CA2520577A1 (fr) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. Composition pharmaceutique
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (fr) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Traitements prophylactiques ou therapeutiques de maladie chronique de la peau
WO2007045980A1 (fr) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de la phosphodiesterase de type iv
WO2015063669A1 (fr) 2013-10-30 2015-05-07 Wockhardt Limited Compositions pharmaceutiques comprenant une combinaison de roflumilast et d'acébrophylline ou de leurs sels pharmaceutiquement acceptables

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0710109T3 (da) * 1993-06-18 2005-01-03 Smithkline Beecham Corp Fremgangsmåde til identifikation af en PDE IV inhibitor
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BR. J. PHARMACOL., vol. 118, no. 5, 1996, pages 1201 - 1208 *
BR. J. PHARMACOL., vol. 119, no. 6, 1996, pages 1255 - 1261 *
DATABASE BIOSIS [online] DEPT. PHARMACOL., KING'S COLL. LONDON, (LONDON, UK); BANNER ET AL.: "The effect of selective phosphodiesterase inhibitors in comparison with other anti-asthma drugs on allergen-induced eosinophilia in Guinea-Pig airways", XP002938256, accession no. STN Database accession no. 1995:554394 *
DATABASE CA [online] DEPARTMENT OF PHARMACOLOGY, GIFU PHARMACEUTICAL UNIVERSITY, (GIFU, JAPAN); KIMATA ET AL.: "Pharmacological modulation of LPS-induced MIP-1 or production by peripheral blood mononuclear cells", XP002938253, accession no. STN Database accession no. 128:265772 *
DATABASE CA [online] DEPARTMENT OF PHARMACOLOGY, KING'S COLLEGE LONDON, (LONDON, ENGLAND); BANNER ET AL.: "The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation", XP002938254, accession no. STN Database accession no. 126:14486 *
DATABASE CA [online] INFLAMMATION BIOLOGY, THERAPEUTICS, LTD. (SLOUGH, UK); GOZZARD ET AL.: "Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase Type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunized rabbits", XP002938255, accession no. STN Database accession no. 125:132083 *
PHARMACOLOGY, vol. 56, no. 5, 1998, pages 230 - 236 *
PULMONERY PHARMACOLOGY, vol. 8, no. 1, 1995, pages 37 - 42 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method

Also Published As

Publication number Publication date
NO20022057L (no) 2002-06-27
SK7592002A3 (en) 2002-11-06
BR0015270A (pt) 2002-06-18
PL355261A1 (en) 2004-04-05
BG106748A (en) 2003-02-28
MA26841A1 (fr) 2004-12-20
NO20022057D0 (no) 2002-04-30
PE20011005A1 (es) 2001-09-28
AR029189A1 (es) 2003-06-18
JP2003513028A (ja) 2003-04-08
AU1357501A (en) 2001-05-14
DZ3225A1 (fr) 2001-05-10
CN1387404A (zh) 2002-12-25
CA2388333A1 (fr) 2001-05-10
CZ20021512A3 (cs) 2003-04-16
IL149367A0 (en) 2002-11-10
EP1225866A2 (fr) 2002-07-31
AP2002002496A0 (en) 2002-06-30
KR20020057988A (ko) 2002-07-12
OA12076A (en) 2006-05-04
TR200201211T2 (tr) 2002-08-21
ECSP003747A (es) 2002-05-23
WO2001032127A2 (fr) 2001-05-10
HUP0203152A3 (en) 2004-06-28
HK1049107A1 (zh) 2003-05-02
HUP0203152A2 (hu) 2003-01-28
EP1225866A4 (fr) 2004-04-21
MXPA02004350A (es) 2002-11-07
ZA200203435B (en) 2003-06-25
CO5261512A1 (es) 2003-03-31
EA200200518A1 (ru) 2002-10-31
TWI242431B (en) 2005-11-01

Similar Documents

Publication Publication Date Title
WO2003011274A3 (fr) Methode therapeutique
EP1602370A3 (fr) Mélange synergétique comprenant un inhibiteur de la rénine pour le traitement des maladies cardiovasculaires
WO2003000241A3 (fr) Nouvelles compositions de medicament a base d'anticholinergiques, de corticosteroides et d'agents beta-mimetiques
WO2004078144A3 (fr) Composes diphenylethylene et leurs utilisations
WO2004021989A3 (fr) Imidazolopyridines, procedes de fabrication et methodes d'utilisation
AU2001278852A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
WO2003051380A3 (fr) Composition destinee au traitement de troubles neurocerebrovasculaires
WO2004078712A3 (fr) Derives d'isoquinoline et leurs methodes d'utilisation
BR9913152A (pt) Terapias para tratamento de doenças pulmonares
IS6444A (is) Pýrimidín karboxamíð nytsamleg sem latar á PDE4 samsætuensím
AU2003235613A1 (en) Crude drug compositions for treating or preventing arthritic diseases and the preparation process
IL100905A0 (en) Pharmaceutical compositions for treatment of pulmonary inflammation
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
BR0009446A (pt) Composto, processo para preparar o mesmo, composição uso de um composto, e, métodos para o tratamento ou a prevenção de uma doença em um mamìfero, para o tratamento ou a prevenção de asma em um mamìfero e para o tratamento ou a prevenção de doença pulmonar obstrutiva crÈnica em um mamìfero
WO2001032127A3 (fr) Procede et compositions pour traiter des maladies respiratoires
WO2005041864A3 (fr) Technique de traitement de prevention d'inflammation respiratoire avec un inhibiteur de cyclooxygenase-2 combine a un inhibiteur de phosphodiesterase 4 et compositions a partir de ceux-ci
WO2004043456A8 (fr) Inhibiteurs d'absorption du cholesterol pour le traitement de la demyelination
IL165378A0 (en) Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
WO2004082706A3 (fr) Traitement de la maladie d'alzheimer
WO1999012933A3 (fr) Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase
WO2003039464A3 (fr) Aerosol antimuscarinique
WO2005011608A3 (fr) Combinaison de deshydroepiandrosterone ou deshydroepiandrosterone-sulfate avec un derive de methylxanthine pour le traitement de l'asthme ou de maladie pulmonaire obstructive chronique
HUP0102388A3 (en) Use of diazepinoindole derivatives for the preparation of pharmaceutical composition treating chronic obstructive pulmonary disease
SE9900834D0 (sv) Novel combination
WO2005011604A3 (fr) Combinaison constituee de deshydroepiandrosterone ou de deshydroepiandrosterone-sulfate et d'un antihistaminique destinee au traitement de l'asthme ou de la bronchopneumopathie chronique obstructive

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AU BA BB BG BR BZ CA CN CZ DZ EE GE GH GM HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX MZ NO NZ PL RO SG SI SK SL TR TT TZ UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AU BA BB BG BR BZ CA CN CZ DZ EE GE GH GM HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX MZ NO NZ PL RO SG SI SK SL TR TT TZ UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 13575/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1200200361

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: 518564

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 149367

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: PV2002-1512

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/004350

Country of ref document: MX

Ref document number: 008152659

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2001 534335

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020027005609

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2388333

Country of ref document: CA

Ref document number: 10129311

Country of ref document: US

Ref document number: 2002/01211

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: 2000975533

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: DZP2002000114

Country of ref document: DZ

ENP Entry into the national phase

Ref document number: 2000 106748

Country of ref document: BG

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 7592002

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: 200200518

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 1020027005609

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2000975533

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV2002-1512

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 2000975533

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)